Depakine

Sodium Valproate (Depakine) is a medication used for various conditions, including seizure disorders and mood stabilization. This intravenous formulation is manufactured by Sanofi S.R.O. and is available in the EU market.

Sodium Valproate, commonly known as Depakine, is primarily used for the treatment of epilepsy and bipolar disorder. It is often prescribed to manage seizures and stabilize mood swings. The intravenous form is typically administered in clinical settings for rapid onset of action.

Common effects of Sodium Valproate may include drowsiness, dizziness, and gastrointestinal discomfort. Some users may experience weight changes or hair loss. These effects can vary depending on individual tolerance and dosage.

Sodium Valproate should be handled with care, especially in patients with liver or pancreatic conditions. Regular monitoring is advised to avoid potential side effects. Always follow healthcare provider instructions for safe usage.

Sodium Valproate may interact with other medications, including certain antiepileptics and antidepressants. It is important to consult a healthcare provider before combining it with other treatments. Alcohol and other CNS depressants should be avoided.